Veterinary Medicine

Brainehealth Logotype White

Revolutionizing Veterinary Medicine with AI Diagnostics

US Patent 11,908,579 B2 powers Diagnosio for 99% accurate care, piloting at Djuriverse Veterinary Clinic in Norrtälje.

Featured in USA News, AP, and 450+ outlets—join our research journey!

Explore AIvet* |  Contact Us

License now for veterinary innovation.

License the Patent

*Swedish site at the moment

Patent Benefits

Patent-Powered Research for Veterinary Innovation

BraineHealth’s US Patent 11,908,579 B2 introduces inversion technology, achieving 99% accuracy for diagnostics, originally developed for human care and now piloting in veterinary medicine.

At Djuriverse Norrtälje Veterinary Clinic, we’re launching a proof-of-principle pilot with KTH thesis workers, adapting the 2018 KTH thesis MATLAB code. This AI, scaling to 20,000+ cases, outperforms Microsoft’s MAI-DxO and targets the $50B+ vet market by 2032.

We’re seeking a large animal symptom/diagnosis database (e.g., Agria) and funding.

Featured in USA News, BizWeekly, and AP (450+ outlets), it’s ripe for licensing.

Key Milestones:

  • Phase 1: Adapt code with developers (3-6 months).
  • Phase 2: Pilot 100-200 cases at Djuriverse.
  • Phase 3: Expand to human care.

Key Benefits:

  • Precision Diagnostics: 99% accuracy reduces misdiagnoses.
  • Scalability: Adapts across species and specialties.
  • Market Advantage: $50B+ vet market potential.

Explore AIvet* |  Contact Us

*Only Swedish version available at the moment.

Patent Benefits

Patent Benefits for Veterinary Medicine

BraineHealth’s US Patent 11,908,579 B2 introduces inversion technology that transforms diagnostics with 99% accuracy, highly adaptable for veterinary medicine where symptoms can be ambiguous.

Originally the patent was developed for human care, this AI scales to 20,000+ cases, handling complex animal data. As Djuriverse Norrtälje Veterinary Clinic demonstrates real-world expertise, this patent offers potential for precision care in companion animals and epidemic management.

Featured in USA news, BizWeekly and AP (450+ outlets), it’s ready for vet applications like tick-borne diseases and orthopedics.

Key Benefits:

Precision Diagnostics: Reduces misdiagnoses with 99% accuracy for reliable results.

Scalability: Adapts to diverse species, from primary to specialized vet care.

Market Advantage: Targets the $50B+ vet market by 2032 with ready-to-license AI.

License the Patent  |  Contact Us for vet-specific details.